[Vasoprotection through vascular nitric oxide. Molecular basis of antiatherosclerotic actions].
Müller
Senta
S
Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität, Moorenstr. 5, 40225 Duesseldorf.
Gewaltig
Michael T
MT
Kojda
Georg
G
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D001808:Blood Vessels / Q000502:physiology*; D006801:Humans; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis; D052250:Nitric Oxide Synthase Type III; D015398:Signal Transduction / Q000502:physiology*
D009569:Nitric Oxide; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III